Ondansetron Injection 4mg/2mL
Adults: Treatment of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention and treatment of postoperative nausea and vomiting (PONV). Pediatric population: Treatment of nausea and vomiting induced by chemotherapy in children ≥ 6 months of age. Prevention and treatment of postoperative nausea and vomiting in children ≥ 1 month of age.
Pharmaceutical form
Injectable
Concentration
4mg/2mL
Combination
N/A
Disclaimer: The content of this website is for pharmaceutical industry professionals interested in creating a strategic alliance with Wexford Laboratories. This page may contain information related to health, medical conditions, physical condition and its treatment. The information contained in this site is not to diagnose a health problem and is not a substitute for the advice provided by your doctor. Always consult a doctor when in doubt about a disease and its treatment. The products are subject to the applicable patent and registration laws of each country, and may not be allowed to be registered in some markets.